Abstract
Factor III (thromboplastin) activity is inhibited by apoB-100, but the mechanism of inhibition is unknown. By examining the effect of purified apoB-100 on factor III activity, we showed that apoB-100 can inhibit factor III via a different mechanism from that caused by the issue-factor pathway-inhibitor, which is mainly carried on the surface of lipoproteins. Although the presence of calcium ions and factors X and VII may enhance the rate of inhibition, they are not a prerequisite for the inhibition of factor III by apoB-100. In addition, by investigating the changes in the UV spectra of apoB-100 on interaction with factor III and factors X and VII and by assigning the shifts in absorption spectra to particular amino acids, we showed that these interactions involve negative and positive residues within these proteins. By following the rates of interactions between apoB-100 and either factors III, X, VII, a two-step mechanism for the inhibition process involving factors X and VII was postulated. In this mechanism, the primary interaction of apoB-100 with factor III is followed by a rate-limiting step that can be accelerated by the presence of either factor X or VII and leads to the inhibition of factor III. Furthermore, a compute...Continue Reading
References
Jan 1, 1978·Annual Review of Biochemistry·P Y Chou, G D Fasman
Mar 25, 1978·Journal of Molecular Biology·J GarnierB Robson
Oct 15, 1992·Thrombosis Research·C Ettelaie, R M Howell
Feb 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·P M SandsetS I Rapaport
Aug 1, 1990·Biochemical Society Transactions·R M Howell, C Ettelaie
Jan 1, 1985·Annual Review of Cell Biology·J L GoldsteinW J Schneider
Nov 15, 1987·Thrombosis Research·S KondoW Kisiel
Nov 21, 1987·Biochimica Et Biophysica Acta·E HerzykD Chapman
Jul 19, 1982·FEBS Letters·C Erlanson-Albertsson, H E Akerlund
Aug 1, 1980·The Biochemical Journal·R M Howell, H Rezvan
Jun 27, 1995·Biochimica Et Biophysica Acta·C EttelaieK R Bruckdorfer
May 1, 1995·Biochemical Society Transactions·K R Bruckdorfer, C Ettelaie
Aug 25, 1994·Nature·K HarlosC W Boys
Citations
Jan 1, 1997·BioFactors·K R BruckdorferM Jacobs
Jul 27, 2001·Archives of Biochemistry and Biophysics·A J ChuS Beydoun
Oct 15, 1998·Thrombosis Research·P Carmeliet, D Collen
Jun 29, 2001·British Journal of Pharmacology·A J ChuS Beydoun
Nov 13, 2001·British Journal of Haematology·A J ChuN Ramos
Jul 26, 2002·British Journal of Haematology·Arthur J ChuEvano Piasentin
Jun 2, 1998·Kidney International·P Carmeliet, D Collen
Mar 27, 2002·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·A J ChuS Beydoun
Nov 7, 2000·Journal of Cardiovascular Pharmacology·A J ChuU O Raphael
Sep 26, 2003·Journal of Cardiovascular Pharmacology·Arthur J ChuSalwa Beydoun
Feb 12, 2011·The Journal of Biological Chemistry·Mary E W Collier, Camille Ettelaie
Jan 16, 1998·Prostaglandins, Leukotrienes, and Essential Fatty Acids·K R Bruckdorfer
Dec 22, 1999·FEBS Letters·C EttelaieK R Bruckdorfer
Apr 21, 1997·Biochimica Et Biophysica Acta·C EttelaieK R Bruckdorfer